LY404187

CAS No. 211311-95-4

LY404187( —— )

Catalog No. M21047 CAS No. 211311-95-4

LY404187 is a positive allosteric modulator of AMPA receptors.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 50 In Stock
2MG 29 In Stock
5MG 46 In Stock
10MG 79 In Stock
25MG 159 In Stock
50MG 233 In Stock
100MG 332 In Stock
200MG 462 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    LY404187
  • Note
    Research use only, not for human use.
  • Brief Description
    LY404187 is a positive allosteric modulator of AMPA receptors.
  • Description
    LY404187 is a positive allosteric modulator of AMPA receptors.
  • In Vitro
    LY-404187 (3-10 nM) potentiates glutamate-evoked inward currents in human GluR4 transfected HEK293 cells.LY-404187 (0.03-10 μM) selectively enhances glutamate-evoked currents through AMPA receptor/channels of acutely isolated pyramidal neurons with considerably greater potency (EC50=1.3±0.3 μM) and efficacy (Emax=45.3±8.0-fold increase) .LY-404187 does not affect the magnitude or time course of wholecell K+ or Na+ currents in pre frontal cortex (PFC) pyramidal neurons at concentrations of 10 μM.
  • In Vivo
    LY-404187 (0.5 mg/kg; s.c for 11 days) can prevent MPTP-induced neurotoxicity in mice.LY-404187 (0.5 mg/kg; s.c. for 28 days) attenuates apomorphine-induced contraversive rotations and affords significant protection against the loss of tyrosine hydroxylase positive nigral cell bodies.LY-404187 (0.1 or 0.5 mg/kg; s.c. for 14 days) affords functional, neurochemical and histological protection after infusion of 6-hydroxydopamine into the substantia nigra in rats.LY-404187 (0.5 mg/kg; s.c. for 14 days) delayed treatment provides functional and histological improvement, suggesting a trophic action as administration is initiated after cell death.LY-404187 (0.1 and 0.5 mg/kg; s.c. for 14 days) increases GAP-43 immunoreactivity in the striatum in a dose-dependent manner. Animal Model:Male C57BL/6J mice (20-25 g) are challenged with MPTP on day 8 Dosage:0.5 mg/kg Administration:S.c; twice daily on weekdays and once daily at weekends for 11 days Result:Attenuated the loss of tyrosine hydroxylase immunoreactivity in the substantia nigra.No significant change in tyrosine hydroxylase immunoreactivity in the dorsal and ventral striatum.
  • Synonyms
    ——
  • Pathway
    Neuroscience
  • Target
    GluR
  • Recptor
    AMPA
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    211311-95-4
  • Formula Weight
    342.46
  • Molecular Formula
    C19H22N2O2S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (292.00 mM)
  • SMILES
    CC(CNS(=O)(=O)C(C)C)c1ccc(-c2ccc(C#N)cc2)cc1
  • Chemical Name
    2-Propanesulfonamide N-(2-(4'-cyano(11'-biphenyl)-4-yl)propyl)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Quirk J C Nisenbaum E S . LY404187: A novel positive allosteric modulator of AMPA receptors[J]. Cns Drug Reviews 2002 8(3):255-282.
molnova catalog
related products
  • gamma-DGG acetate(67...

    gamma-DGG acetate(6729-55-1 free base) (γ-D-Glutamylglycine) is a competitive blocker of AMPA receptor.

  • 1-ethyl-3-morpholin-...

    1-ethyl-3-morpholin-4-yl-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile is a positive allosteric modulator of mGluR3 and can be used in studies about the treatment of Parkinson's disease.

  • (E/Z)-SIB-1893

    (E/Z)-SIB-1893 (SIB 1893) is the racemate of (E)-SIB-1893 and (Z)-SIB-1893. (E)-SIB-1893 is a selective, noncompetitive mGluR5 antagonist with anticonvulsant activity .